NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of The Beauty Health Company (“Beauty Health” or the “Company”) (NASDAQ: SKIN).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com  or 646-581-9980, ext. 7980.